Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-05-15 to 2025-06-06
Current total value of award: $9566.32
Description: 4568273872!OMIDRIA 1-0.3% VIAL 4ML